Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Shanghai Haohai Biological Technology Co., Ltd. Class H ( (HK:6826) ) has shared an announcement.
Shanghai Haohai Biological Technology Co., Ltd. has announced proposed amendments to its Articles of Association, which include abolishing the supervisory committee and transferring its responsibilities to the audit committee. These changes align with recent regulatory updates in China and Hong Kong, aiming to streamline governance structures and incorporate electronic voting and hybrid shareholder meetings. The amendments are subject to shareholder approval at the upcoming annual general meeting.
More about Shanghai Haohai Biological Technology Co., Ltd. Class H
Shanghai Haohai Biological Technology Co., Ltd. is a company based in China, operating in the biotechnology industry. The company focuses on developing and providing biological materials and medical devices.
Average Trading Volume: 585,957
Technical Sentiment Signal: Sell
Current Market Cap: HK$12.06B
For a thorough assessment of 6826 stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue